STOCK TITAN

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
partnership
AbbVie has announced a multi-year partnership with the Chicago Cubs called 'Striking Out Cancer' to support cancer patients and advocacy. Starting May 2025, AbbVie will donate $233 for every Cubs pitcher strikeout at home games during the 2025 regular season, with the amount symbolizing the 233 Americans diagnosed with cancer hourly. The donations will go to Cubs Charities supporting non-profit cancer organizations, including Conquer Cancer, the ASCO Foundation. This initiative aligns with AbbVie's mission as a biopharmaceutical company developing therapies for various conditions, including leukemias, lymphomas, lung and gynecological cancers.
AbbVie ha annunciato una partnership pluriennale con i Chicago Cubs chiamata "Striking Out Cancer" per supportare i pazienti oncologici e la sensibilizzazione. A partire da maggio 2025, AbbVie donerà 233 dollari per ogni strikeout effettuato da un lanciatore dei Cubs nelle partite casalinghe della stagione regolare 2025, un importo che rappresenta i 233 americani diagnosticati con il cancro ogni ora. Le donazioni saranno destinate a Cubs Charities, che sostiene organizzazioni no-profit contro il cancro, tra cui Conquer Cancer, la fondazione ASCO. Questa iniziativa è in linea con la missione di AbbVie, azienda biofarmaceutica che sviluppa terapie per diverse patologie, tra cui leucemie, linfomi, tumori polmonari e ginecologici.
AbbVie ha anunciado una asociación plurianual con los Chicago Cubs llamada "Striking Out Cancer" para apoyar a pacientes con cáncer y la defensa de esta causa. A partir de mayo de 2025, AbbVie donará 233 dólares por cada ponche realizado por un lanzador de los Cubs en los partidos en casa durante la temporada regular de 2025, una cifra que simboliza los 233 estadounidenses diagnosticados con cáncer cada hora. Las donaciones se destinarán a Cubs Charities, que apoya organizaciones sin fines de lucro contra el cáncer, incluyendo Conquer Cancer, la Fundación ASCO. Esta iniciativa está alineada con la misión de AbbVie como empresa biofarmacéutica que desarrolla terapias para diversas condiciones, incluyendo leucemias, linfomas, cáncer de pulmón y ginecológico.
AbbVie는 암 환자 지원 및 옹호를 위해 시카고 컵스와 'Striking Out Cancer'라는 다년간의 파트너십을 발표했습니다. 2025년 5월부터 AbbVie는 2025년 정규 시즌 동안 홈 경기에서 컵스 투수가 기록하는 삼진 1개당 233달러를 기부할 예정이며, 이 금액은 매시간 233명의 미국인이 암 진단을 받는 것을 상징합니다. 기부금은 비영리 암 단체를 지원하는 Cubs Charities에 전달되며, 여기에는 Conquer Cancer, ASCO 재단이 포함됩니다. 이 이니셔티브는 백혈병, 림프종, 폐암 및 부인암 등 다양한 질환에 대한 치료제를 개발하는 생명공학 회사인 AbbVie의 사명과 일치합니다.
AbbVie a annoncé un partenariat pluriannuel avec les Chicago Cubs intitulé « Striking Out Cancer » pour soutenir les patients atteints de cancer et la sensibilisation. À partir de mai 2025, AbbVie fera un don de 233 dollars pour chaque retrait sur prise réalisé par un lanceur des Cubs lors des matchs à domicile de la saison régulière 2025, ce montant symbolisant les 233 Américains diagnostiqués avec un cancer chaque heure. Les dons seront versés à Cubs Charities, qui soutient des organisations caritatives contre le cancer, dont Conquer Cancer, la fondation ASCO. Cette initiative s’inscrit dans la mission d’AbbVie, une entreprise biopharmaceutique développant des thérapies pour diverses pathologies, notamment les leucémies, lymphomes, cancers du poumon et gynécologiques.
AbbVie hat eine mehrjährige Partnerschaft mit den Chicago Cubs unter dem Namen „Striking Out Cancer“ angekündigt, um Krebspatienten und deren Interessenvertretung zu unterstützen. Ab Mai 2025 wird AbbVie für jeden Strikeout eines Cubs-Pitchers bei Heimspielen während der regulären Saison 2025 233 US-Dollar spenden. Dieser Betrag symbolisiert die 233 Amerikaner, die stündlich mit Krebs diagnostiziert werden. Die Spenden gehen an Cubs Charities, die gemeinnützige Krebsorganisationen, darunter Conquer Cancer, die ASCO-Stiftung, unterstützt. Diese Initiative steht im Einklang mit AbbVies Mission als biopharmazeutisches Unternehmen, das Therapien für verschiedene Erkrankungen wie Leukämien, Lymphome, Lungen- und gynäkologische Krebserkrankungen entwickelt.
Positive
  • None.
Negative
  • None.

Chicago-based institutions aim to create greater awareness for cancer advocacy and to support non-profit cancer organizations

NORTH CHICAGO, Ill., May 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced a multi-year partnership with the Chicago Cubs to support people living with cancer through a campaign called "Striking Out Cancer" which starts today when the Chicago Cubs play the Cincinnati Reds. As part of the first year of the partnership, AbbVie will make a $233 donation for every strikeout by a Chicago Cubs pitcher at home during the 2025 regular season. The donation amount is in honor of the approximately 233 Americans diagnosed with cancer every hour, according to the American Cancer Society. 1

"Every strikeout this Chicago Cubs season is more than a statistic on the scoreboard – it is a step forward in supporting those living with and fighting cancer," said Tracie Haas, senior vice president, corporate affairs, AbbVie. "Together with our hometown partner the Chicago Cubs, we aim to create greater awareness for cancer advocacy and to make a remarkable impact for those living with cancer worldwide."

The total amount raised throughout the 2025 regular season will be donated to Cubs Charities in support of not-for-profit organizations working to advance the fight against cancer. This year's donations will be provided to Conquer Cancer®, the ASCO Foundation, a 501(c)(3) charitable organization focused on accelerating breakthroughs in lifesaving research and empowering people everywhere to conquer cancer, among other cancer not-for-profit organizations.

The campaign aligns with AbbVie's mission as a global biopharmaceutical company that discovers and delivers transformative medicines that help to solve serious health issues across several therapeutic areas including immunology, oncology, neuroscience and eye care, and products and services in our Allergan Aesthetics portfolio. In oncology, AbbVie's therapies for leukemias, lymphomas, lung and gynecological cancers are helping  patients across the world.

"We're honored to team up with AbbVie and do our part to help strikeout cancer," said Alex Seyferth, vice president, Cubs Corporate Partnerships. "Every dollar raised will go to organizations on the front line of fighting this terrible disease. Together, the Cubs and AbbVie are committed to raising awareness and donations to help those impacted by cancer."

"We're incredibly grateful to be a beneficiary of the 'Striking Out Cancer' campaign," said Nancy R. Daly, chief executive officer, Conquer Cancer. "The support from AbbVie and Cubs Charities is vital, enabling us to advance our critical work and bringing us closer to achieving our vision of a world where cancer is prevented or cured, and every survivor is healthy."

The "Striking Out Cancer" campaign launches in May 2025 and will run through the end of the 2025 Chicago Cubs regular season in its first year.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, FacebookInstagramX (formerly Twitter), and YouTube. 

About the Chicago Cubs
The Chicago Cubs franchise, a charter member of Major League Baseball's National League since 1876, has won the National League pennant 17 times and was the first team to win back-to-back World Series titles in the 1907 and 1908 seasons. In 2016, the Chicago Cubs made history again when the team won its first World Series in 108 years, ending the longest championship drought in North American sports. Known for its ivy-covered outfield walls, hand-operated scoreboard and famous Marquee, iconic Wrigley Field has been the home of the Chicago Cubs since 1916 and is the second oldest ballpark in Major League Baseball. In 2009, the Ricketts family assumed ownership of the Chicago Cubs. The organization's three main goals are: Win the World Series, Create the World's Best Guest Experience and Be a Good Neighbor. For more information, visit www.cubs.com.

About Cubs Charities
Cubs Charities is a nonprofit that mobilizes the power of sport to champion youth, families and communities. Cubs Charities' work is focused on sports-based youth development and academic programming, investments in safe places to play and strategic grantmaking. Since 2009, Cubs Charities has invested more than $51 million in people, places and programs across Chicago. Cubs Charities is a leader among professional sports teams in its creation, execution and delivery of quality, sports-based youth development programming. Today, Cubs Charities' portfolio includes programs that provide children and youth with skilled coaches, quality programming and safe and accessible places to play the game. Learn more at www.cubscharities.org. and follow @CubsCharities on social media.

About Conquer Cancer®, the ASCO Foundation
Conquer Cancer funds research for every cancer, to help every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $203 million through more than 9,800 grants and awards to improve cancer care and accelerate breakthroughs in clinical and translational oncology research. Conquer Cancer donors support vital programs needed to deliver the highest quality patient care and share a vision of a world where cancer is prevented or cured, and every survivor is healthy. For more information visit CONQUER.ORG

U.S. Media:

Investors:



Gabrielle Tarbert

Liz Shea

gabrielle.tarbert@abbvie.com 

liz.shea@abbvie.com



Ilke Limoncu 


ilke.limoncu@abbvie.com 


 

1 https://cancerstatisticscenter.cancer.org/

AbbVie logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-partners-with-chicago-cubs-on-striking-out-cancer-302469190.html

SOURCE AbbVie

FAQ

What is AbbVie's 'Striking Out Cancer' partnership with the Chicago Cubs?

It's a multi-year partnership where AbbVie donates $233 for every Cubs pitcher strikeout at home games during the 2025 season to support cancer organizations through Cubs Charities.

How much will ABBV donate per strikeout in the Cubs partnership?

AbbVie will donate $233 per strikeout by Chicago Cubs pitchers at home games, representing the 233 Americans diagnosed with cancer every hour.

Which organizations will benefit from AbbVie's Cubs partnership?

The donations will support Cubs Charities and benefit organizations including Conquer Cancer, the ASCO Foundation, and other cancer non-profit organizations.

When does AbbVie's 'Striking Out Cancer' campaign begin?

The campaign launches in May 2025 and will run through the end of the 2025 Chicago Cubs regular season.

What types of cancer treatments does AbbVie (ABBV) currently develop?

AbbVie develops therapies for leukemias, lymphomas, lung and gynecological cancers to help patients worldwide.
Abbvie Inc

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

322.44B
1.76B
0.12%
74.08%
1.05%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NORTH CHICAGO